Introduction of extended LEC14-type branching into core-fucosylated biantennary N-glycan: Glycoengineering for enhanced cell binding and serum clearance of the neoglycoprotein

FEBS Journal

Volumn 272, Issue 8, 2005, Pages 1986-1998

  André, Sabine ^a   Kojima, Shuji ^b   Prahl, Ingo ^c   Lensch, Martin ^a   Unverzagt, Carlo ^c   Gabius, Hans Joachim ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Drug targeting; Galectin; Glycosylation; Lectin; Tumor imaging

Indexed keywords

GALACTOSIDE; GLYCAN DERIVATIVE; LECTIN; MANNOSE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; NEOGLYCOPROTEIN; OLIGOSACCHARIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL ORGANELLE; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; FUCOSYLATION; HUMAN; HUMAN CELL; LECTIN BINDING; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL;

AGGLUTININS; ANIMALS; CARBOHYDRATE SEQUENCE; CELL LINE; CELL LINE, TUMOR; EPITOPES; FLOW CYTOMETRY; FUCOSE; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; LECTINS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; POLYSACCHARIDES; PROTEIN BINDING; TISSUE DISTRIBUTION;

EID: 17444365412     PISSN: 1742464X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2005.04637.x     Document Type: Article

References (59)

1. Brockhausen I & Schachter H (1997) Glycosyltransferases involved in N- and O-glycan biosynthesis. In Glycosciences: Status and Perspectives (Gabius H-J & Gabius S, eds), pp. 79-113. Chapman & Hall, Weinheim.
2. Reuter G & Gabius H-J (1999) Eukaryotic glycosylation: whim of nature or multipurpose tool? Cell Mol Life Sci 55, 368-422.
3. Haltiwanger RS & Lowe JB (2004) Role of glycosylation in development. Annu Rev Biochem 73, 491-537.
4. Laine RA (1997) The information-storing potential of the sugar code. In Glycosciences: Status and Perspectives (Gabius H-J & Gabius S, eds), pp. 1-14. Chapman & Hall, Weinheim.
5. Gabius H-J, Siebert H-C, André S, Jiménez-Barbero J & Rüdiger H (2004) Chemical biology of the sugar code. Chembiochem 5, 740-764.
6. Gabius H-J, André S, Kaltner H & Siebert H-C (2002) The sugar code: functional lectinomics. Biochim Biophys Acta 1572, 165-177.
7. Schrag JD, Procopio DO, Cygler M, Thomas DY & Bergeron JJM (2003) Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem Sci 28, 49-57.
8. Yoshida Y (2003) A novel role for N-glycans in the ERAD system. J Biochem 134, 183-190.
9. Gabius H-J (1997) Animal lectins. Eur J Biochem 243, 543-576.
10. Kaltner H & Stierstorfer B (1998) Animal lectins as cell adhesion molecules. Acta Anat 161, 162-179.
11. Kilpatrick DC (2002) Animal lectins: a historical introduction and overview. Biochim Biophys Acta 1572, 187-197.
12. André S, Unverzagt C, Kojima S, Dong X, Fink C, Kayser K & Gabius H-J (1997) Neoglycoproteins with the synthetic complex biantennary nonasaccharide or its α2,3/α2,6-sialylated derivatives: their preparation, assessment of their ligand properties for purified lectins, for tumor cells in vitro, and in tissue sections, and their biodistribution in tumor-bearing mice. Bioconjugate Chem 8, 845-855.
13. Unverzagt C, André S, Seifert J, Kojima S, Fink C, Srikrishna G, Freeze H, Kayser K & Gabius H-J (2002) Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional α2,3/α2,6 sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake. J Med Chem 45, 478-491.
14. André S, Unverzagt C, Kojima S, Frank M, Seifert J, Fink C, Kayser K, von der Lieth C-W & Gabius H-J (2004) Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silica, in vitro and in vivo. Eur J Biochem 271, 118-134.
15. Ripka J & Stanley P (1986) Lectin-resistant CHO cells: selection of four new pea lectin-resistant phenotypes. Somat Cell Mol Genet 12, 51-62.
16. Stanley P, Raju TS & Bhaumik M (1996) CHO cells provide access to novel N-glycans and developmentally regulated glycosyltransferases. Glycobiology 6, 695-699.
17. Rüdiger H & Gabius H-J (2001) Plant lectins. Glycoconjugate J 18, 589-613.
18. Raju TS & Stanley P (1996) LEC14, a dominant Chinese hamster ovary glycosylation mutant expresses complex N-glycans with a new N-acetylglucosamine residue in the core region. J Biol Chem 271, 7484-7493.
19. Raju TS & Stanley P (1998) Gain-of-function Chinese hamster ovary mutants LEC18 and LEC14 each express a novel N-acetylglucosaminyltransferase activity. J Biol Chem 273, 14090-14098.
20. Narasimhan S, Freed JC & Schachter H (1985) Control of glycoprotein synthesis. Bovine milk UDP-galactose: N-acetylglucosamine β-4- galactosyltransferase catalyzes the preferential transfer of galactose to the Glc-NAcβ1,2Manα1,3-branch of both bisected and nonbisected complex biantennary asparagine-linked oligosaccharides. Biochemistry 24, 1694-1700.
21. Wang Y, Tan J, Sutton-Smith M, Ditto D, Panico M, Campbell RM, Varki NM, Long JM, Jaeken J, Levinson SR, Wynshaw-Boris A, Morris HR, Le D, Dell A, Schachter H & Marth JD (2001) Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 11, 1051-1070.
22. Prahl I & Unverzagt C (2000) Synthesis of a LEC14 nonasaccharide, a core-fucosylated, biantennary N-glycan with a novel GlcNAc residue in the core region. Tetrahedron Lett 41, 10189-10193.
23. Prahl I & Unverzagt C (2002) Enzymatic elongation of the LEC14 antigen generates a β-1,2 arm on N-glycans. Angew Chem Int Ed 41, 4259-4262.
24. Lahm H, André S, Hoeflich A, Kaltner H, Siebert H-C, Sordat B, von der Lieth C-W, Wolf E & Gabius H-J (2004) Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconjugate J 20, 227-238.
25. Wu AM, Wu JH, Tsai M-S, Kaltner H & Gabius H-J (2001) Carbohydrate specificity of a galectin from chicken liver (CG-16). Biochem J 358, 529-538.
26. Wu AM, Wu JH, Tsai M-S, Liu J-H, André S, Wasano K, Kaltner H & Gabius H-J (2002) Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract. Biochem J 367, 653-664.
27. Wu AM, Wu JH, Liu J-H, Singh T, André S, Kaltner H & Gabius H-J (2004) Effects of poly valency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galβ1-terminated core saccharides on the binding of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochimie 86, 317-326.
28. Rüdiger H, Siebert H-C, Solís D, Jiménez-Barbero J, Romero A, von der Lieth C-W, Díaz-Mauriño T & Gabius H-J (2000) Medicinal chemistry based on the sugar code: fundamentals of lectinology and experimental strategies with lectins as targets. Curr Med Chem 7, 389-416.
29. Yamazaki N, Kojima S, Bovin NV, André S, Gabius S & Gabius H-J (2000) Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev 43, 225-244.
30. Davis BJ & Robinson MA (2002) Drug delivery systems based on sugar-macromolecule conjugates. Curr Opin Drug Discov Develop 5, 279-288.
31. Faye L & Chrispeels MJ (1988) Common antigenic determinants in the glycoproteins of plants, molluscs and insects. Glycoconjugate J 5, 245-256.
32. Khoo KH, Huang HH & Lee KM (2001) Characteristic structural features of schistosome cercarial N-glycans: expression of Lewis X and core xylosylation. Glycobiology 11, 149-163.
33. van Ree R (2002) Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol 129, 189-197.
34. López-Lucendo MF, Solís D, André S, Hirabayashi J, Kasai K-i, Kaltner H, Gabius H-J & Romero A (2004) Growth-regulatory human galectin-1: crystallographic characterization of the structrual changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J Mol Biol 343, 957-970.
35. Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, Cantz M & Gabius H-J (2001) Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 276, 35917-35923.
36. Brewer CF (2002) Binding and cross-linking properties of galectins. Biochim Biophys Acta 1572, 255-262.
37. Massa SM, Cooper DNW, Leffler H & Barondes SH (1993) L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry 32, 260-267.
38. Ahmad N, Gabius H-J, André S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F & Brewer CF (2004) Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem 279, 10841-10847.
39. Manning JC, Seyrek K, Kaltner H, André S, Sinowatz F & Gabius H-J (2004) Glycomic profiling of developmental changes in bovine testis by lectin histochemistry and further analysis of the most prominent alteration on the level of the glycoproteome by lectin blotting and lectin affinity chromatography. Histol Histopathol 19, 1043-1060.
40. André S, Frisch B, Kaltner H, Desouza DL, Schuber F & Gabius H-J (2000) Lectin-mediated drug targeting. Selection of valency, sugar type (Gal/Lac) and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectins. Pharmaceut Res 17, 985-990.
41. Raju TS, Briggs JB, Chamow SM, Winkler ME & Jones AJS (2001) Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. Biochemistry 40, 8868-8876.
42. Elliott S, Lorenzini T, Asher S, Aoki K, Brankow D, Buck L, Busse L, Chang D, Fuller J, Grant J, Hernday N, Hokum M, Hu S, Knudten A, Levin N, Komorowski R, Martin F, Navarro R, Osslund T, Rogers G, Rogers N, Trail G & Egrie J (2003) Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol 21, 414-420.
43. Koury MJ (2003) Sugar coating extends half-lives and improves effectiveness of cytokine hormones. Trends Biotechnol 21, 462-464.
44. Perlman S, van den Hazel B, Christiansen J, Gram-Nielsen S, Jeppesen CB, Andersen KV, Halkier T, Okkels S & Schambye HT (2003) Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. J Clin Endocrinol Metab 88, 3227-3235.
45. 1-Fc antibody protein generates neoglycoproteins with enhanced function. Chem Biol 10, 807-814.
46. Elliott S, Chang D, Delorme E, Eris T & Lorenzini T (2004) Structural requirements for additional N-linked carbohydrate on recombinant human erythropoietin. J Biol Chem 279, 16854-16862.
47. Sato M, Sadamoto R, Niikura K, Monde K, Kondo H & Nishimura S-I (2004) Site-specific introduction of sialic acid into insulin. Angew Chem Int Ed 43, 1516-1520.
48. André S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K & Gabius H-J (1999) Galectins-1 and -3 and their ligands in tumor biology. J Cancer Res Clin Oncol 125, 461-474.
49. Gabius H-J, Darro F, Remmelink M, André S, Kopitz J, Danguy A, Gabius S, Salmon I & Kiss R (2001) Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts. Cancer Invest 19, 114-126.
50. André S, Liu B, Gabius H-J & Roy R (2003) First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. Org Biomol Chem 1, 3909-3916.
51. Kopitz J, André S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu F-T, Cantz M, Heck AJR & Gabius H-J (2003) Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 22, 6277-6288.
52. André S, Kaltner H, Furuike T, Nishimura S-I & Gabius H-J (2004) Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjugate Chem 15, 87-98.
53. Morris S, Ahmad N, André S, Kaltner H, Gabius H-J, Brenowitz M & Brewer CF (2004) Quaternary solution structures of galectins-1, -3 and -7. Glycobiology 14, 293-300.
54. 1 in silico and in vitro on human neuroblastoma cells. Int J Cancer 114, 46-57.
55. Purkrábková T, Smetana K Jr, Dvořankova B, Holíková Z, Böck C, Lensch M, André S, Pytlík R, Liu F-T, Klíma J, Smetana K, Motlik J & Gabius H-J (2003) New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites. Biol Cell 95, 535-545.
56. Gabius S, Joshi SS, Gabius H-J & Sharp JG (1991) Establishment, characterization and determination of cell surface sugar receptor (lectin) expression by neoglycoenzymes of a human myeloid-marker-expressing B-lymphoblastoid cell line. Anticancer Res 11, 793-800.
57. Kojima S, Shimura N, Kubodera A, Takahashi T & Oyamada H (1991) Radioimmunodetection of human colon cancer in nude mice by a new monoclonal antibody A7 against human colorectal cancer. Nucl Med Biol 18, 847-853.
58. Kojima S & Gabius H-J (1988) Biodistribution of neoglycoproteins in mice bearing solid Ehrlich tumor. J Cancer Res Clin Oncol 114, 468-472.
59. Kojima S, André S, Korchagina EY, Bovin NV & Gabius H-J (1997) Tyramine-containing poly (4-nitro-phenylacrylate) as iodinatable ligand carrier in biodistribution analysis. Pharmaceut Res 14, 879-886.